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A B S T R A C T  
Objective: The study was conducted to compare the effect of Beclomethasone dipropionate with mast cell stabilizer on 
mucociliary clearance in patients of allergic rhinitis. 
Patients and Methods: A randomized trial was carried out in ENT department of Nishtar Hospital Multan from 
December 2016 to February 2017. Patients of allergic rhinitis from both genders were included in the study after written 
consent. Mucociliary transport velocity was measured by saccharine dye test. The collected data was processed and 
analyzed by SPSS software 23 version and presented in tabulation form. Qualitative variables were analyzed in 
percentage and frequency form. The main outcome variable, mucociliary transport velocity, age and weight of patients 
were presented as mean and stranded deviation. Students’ test was applied to calculate p value. P value <0.05 was 
taken as significant. 
Results: A total number of 140 patients were included in the study and were divided in two main groups. There were 70 
volunteers in each group.  One group was provided Beclomethasone and other group was given mast cell stabilizer for 
one week.  After careful analysis and calculation, it was observed that the mean of mucociliary transport velocity after 
one week of Beclomethasone dipropionate treatment was 7.33±1.27 mm/minute with p value 0.558 and mean of velocity 
after mast cell stabilizer (Nedocromil sodium) was 7.82±1.2 mm/minute with p-values 0.304. 
Conclusion: No statistical significance was found with both treatment regimens. 
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I n t r o d u c t i o n  
 
In upper respiratory disorders, allergic rhinitis has 
important correlation with asthmatic complications.1 Its 
prevalence in United States ranges between 5 to 22 
percent. Major symptoms of allergic rhinitis are pruritus of 
nose and eyes, rhinorrhea, nasal congestion and 
sneezing. Less common symptoms include popping of 
ears, coughing and throat clearing.2 Chronic breathing 
disease and the consequences of allergic rhinitis 
complications like sinusitis, Eustachian tube dysfunction 
and sleep disturbances are major complications which 
result in morbidity.3 Parental history of atopic disease 
increases the chance of disease occurrence in next 
generation by 30 percent and even more risk when both 
parents have such disease.4 Allergic rhinitis as itself 
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explains is the hypersensitivity response to the external 
allergens mediated by IgE antibodies. Its outcomes are 
nasal symptoms or upper respiratory tract disturbances 
presenting as its main hallmarks. There is a list of 
allergens, which are the cause of this hypersensitivity. 
These include trees and small plants pollens, house dust, 
insects and some foods.5 
In allergic rhinitis, mast cells and basophils are first line of 
defense, which has high affinity receptors for IgE 
antibodies and second line of defense are Eosinophils, 
Monocytes and Platelets with low affinity receptors.6 It is 
not necessary that all the subjects having IgE serum level 
show clinical significance. It is also understood that there 
is no probability of any specific organ to be effected by 
increase in IgE serum level. Although in allergic rhinitis 
patients mast cells degranulate, causing release of 
inflammatory mediators, which ultimately lead to 
stimulation of nasal end organs, producing different 
symptoms like sneezing, itching, nasal congestion and 
rhinorrhea.7 Among the persons with raised IgE serum 
level and positive skin sensitivity test, about 90 percent 
population show immediate hypersensitivity response 
followed by the symptoms stated above.  
Mediators released by first and second line defenders 
show collective symptomatic response with less 
information about individual exact response, although 
some individual response has been discussed on the 
base of nasal provocation tests. Histamine causes acute 
antigen antibody response, serotonin causes sneezing 
and rhinorrhea without congestion while leukotrienes and 
prostaglandins cause rhinorrhea and congestion both.8 To 
cope with this nasal disease there are different ways of 
therapy. Before treatment, avoidance from the causative 
factors are more important as care is the best health 
remedy. All the sources of pollens, dust and other 
hypersensitive allergens must be avoided to cope with 
this disease. Otherwise frequently used medicines for the 
treatment of allergic rhinitis are antihistamines, 
decongestants, nedocromil sodium (NDS) and 
glucocorticoids.9 Immunotherapy is also preferred to lower 
the threshold for development of clinical symptoms by 
injecting a series of injections with allergens.   
Antihistamines provocation includes rapid onset and 
reducing sneezing, rhinorrhea and pruritus but not 
congestion. Decongestants like pseudoephedrine 
hydrochloride with alpha-adrenergic agonist properties 
constrict the nasal vascular bed, which results in 
decreased blood supply, and thus lowering of mucosal 
edema. Nedocromil sodium (NDS), a frequently used 
mast cell stabilizer is also the same in effectiveness as 
antihistamines.10 Glucocorticoids that include Flunisolide, 
Beclomethasone Dipropionate and Dexamethasone are 
very potent and preferred drugs for the treatment of 
allergic rhinitis. There mode of action is the same as that 
of antihistamines with rapid onset reducing 
hypersensitivity symptoms. 
To evaluate the efficacy and to find out the significant 
difference in treatment effects, different drugs have been 
compared in different studies. In this study, two drug 
groups discussed above have been focused to evaluate 
their therapeutic efficiency by certain tests. The two drugs 
are Beclomethasone dipropionate (BDP) a 
glucocorticosteroid and Nedocromil sodium (NDS) a mast 
cell stabilizer, both provocation results effect on 
mucociliary clearance.11 There are many tests used to 
evaluate the mucociliary clearance like saccharine test, 
dye method and radiographic method. Saccharine test is 
inexpensive and reliable technique frequently preferred 
for the mucociliary clearance measurement.12 The study 
was conducted to evaluate the difference between the 
efficacies of two drugs on allergic rhinitis. 
P a t i e n t s  a n d  M e t h o d s  
This prospective study was conducted in ENT department 
of Nishtar Medical College and Hospital Multan from 
December 2016 to February 2017 on patients of allergic 
rhinitis. After proper approval from institutional ethical 
committee, a total 140 patients, of both gender were 
included in this study. Sample size was calculated by 
using online software raosoft by using reference study of 
Svendsen and colleagues with confidence interval 95%.13 
A written consent was taken from the participants with 
verbal briefing about procedure, purpose and protocol of 
study. Patients were divided into two main groups 
randomly by lottery method and allocated to drugs 
Beclomethasone dipropionate and Nedocromil sodium 
(NDS) in equal ratio.14 Inclusion criteria was nonsmokers, 
no history of asthma, no previous chronic upper and lower 
respiratory disease, no nasal structural abnormality. Only  
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patients with acute allergic rhinitis were included in the 
study.15 Patients already treated with Beclomethasone 
dipropionate and Nedocromil sodium (NDS) were 
excluded from the study. 
All selected patients were gone through mucociliary 
function test to measure mucociliary transport velocity at 
baseline and after treatment with Beclomethasone 
dipropionate and Nedocromil sodium (NDS). To measure 
mucociliary transport velocity (mm/min), saccharine dye 
test was applied.16 The test was preferred as it was 
inexpensive, readily available, easy to perform and 
reproducible. A particle of saccharine with special blue 
dye was placed on the anteriomedial portion of the inferior 
turbinate at the point 4 cm apart from the nasal tip. The 
transport time was measured from the time of application 
of saccharine with dye up to the sweet taste in mouth. It 
was further confirmed by blue dye in the pharynx. The 
length of nasal cavity was measure with the help of cotton 
swab from the nasal tip to the pharyngeal wall.17 With the 
help of measured transport time and length of nasal cavity 
mucociliary transport velocity (mm/min) was calculated. 
The same procedure was repeated on the same nostrils 
after one-week treatment of both medicine groups i.e. 1st 
group treated with Beclomethasone dipropionate and 2nd  
 
group treated with NDS. Mucociliary transport velocity 
was calculated according to same method as before 
treatment. The daily dose during treatment was, 4 mg 
Nedocromil sodium (2 mg per puff) and 0.1 mg 
Beclomethasone dipropionate (0.05 mg per puff) two time 
each medicine daily. Treatment was continued for one 
week on each group.18 
All the data were collected and saved in excel 
spreadsheets and SPSS version 23. Main outcome 
variable of current study was mucociliary transport 
velocity, which was calculated by transport time, and 
nasal length expressed as mm/min. Qualitative data like 
gender were analyzed in percentage and frequency. The 
main outcome variable mucociliary transport velocity, age 
and weight of patients were presented as mean and 
standard deviation. Paired sample t-test was applied to 
calculate p value and p-value ≤ 0.05 was taken as 
statistically significant.  
R e s u l t s  
Total 140 patients of both genders were included in this 
study. Gender distribution showed that there were more 
males (69.3%) than females (30.7%). Mean age and 
weight of the patients was 32.65±4.93 years and 
62.22±4.93 kg respectively. Majority of the patients 
(65.7%) were in age group 31-45 years. Weight 
distribution showed that large number of patients (61.4%) 
had weight between 61-70 kg (Table 1). Mean age and 
weight of the patients treated with Beclomethasone was 
29.81±3.25years and 60.64±3.40 kg respectively. While 
the mean age and weight of the patients treated with NDS 
was 35.48±4.69 years and 63.8±5.68 kg respectively 
(Table 2). Mean mucociliary transport velocity of the 
patients in two groups at baseline and after one week of  
Table 1: Demographic characteristics of study 
participants (n=140) 
Characteristics Frequency  Percentage  
Gender 
Male 97 69.3 
Female 43 30.7 
Stratified Age (years) 
20-30  48 34.3 
31-45  92 65.7 
Stratified Weight (kg) 
50-60  54 38.6 
61-71  86 61.4 
Descriptive Statistics 
Age (years) Mean±SD  
32.65±4.93 
Weight (kg) 62.22±4.93 
Table 2: Group wise demographic characteristics of 
participants 
Groups Variable Mean±SD 
Beclomethasone 
(n=70) 
Age (years)  29.81±3.25  
Weight (kg) 60.64±3.40  
Nedocromil sodium 
(n=70) 
Age (years) 35.48±4.69  
Weight (kg) 63.80±5.68  
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treatment was statistically insignificant with p-values 
0.558 and 0.304 respectively (Table 3).  
D i s c u s s i o n  
Allergic rhinitis is directly correlated with different upper 
respiratory complications leading to acute or chronic 
respiratory diseases. Therefore, different treatment 
strategies are implemented to overcome this disease. 
Antihistamines, decongestants, Nedocromil sodium 
(NDS), glucocorticoids and immunotherapy are the 
preferred modes of treatment. Above all self-care and 
health consciousness are also very important factors to 
avoid these kinds of diseases. In current study, the two 
groups of drugs used in the treatment of this disease 
have been compared in their efficacy. Many studies have 
been presented by different researches on the effects of 
drugs discussed above, over different aspects of 
treatment outcome. Ratner et al in 2002 had conducted a 
research on the effect of Cromolyn sodium on allergic 
rhinitis, which showed positive results of drug relieving the 
major symptoms caused by allergic rhinitis.19 We focused 
on the comparison of treatment efficacy of glucocorticoids 
(Beclomethasone dipropionate) and mast cell stabilizer 
(Nedocromil sodium (NDS). The treatment efficacy was 
evaluated on the basis of mucociliary transport velocity in 
nasal cavity by saccharine dye test. Pelucchi et al in 1995 
described the effectiveness of intranasal Azelastine and 
Beclomethasone dipropionate on seasonal nasal 
symptoms which showed that the later drug had better 
treatment outcome.20 A study presented by Watson et al 
in 1993 showed the effects of Beclomethasone on 
treatment of allergic rhinitis with asthmatic complications 
compared with placebo.  The results concluded the direct 
effect on upper respiratory symptoms due to allergic 
rhinitis and indirect positive effect on lower respiratory 
complications like asthma.21 Svendsen et al in 1989 
proposed in their research there was no significant 
difference in efficacy of Nedocromil sodium and 
Beclomethasone dipropionate in the treatment of allergic 
rhinitis accompanied by asthmatic respiratory disorders.21 
Another study by stafanger et al in 1987 showed effect of 
Beclomethasone dipropionate and Flunisolide on the 
movement of nasal cilia obtained from healthy volunteers 
by gentle scraping. The results showed a minor but 
irreversible decrease in Ciliary Beating Frequency (CBF) 
of the cilia by both drugs.22 
Rudd et al in 1983 described the effect of orally taken 
mast cell stabilizers on exercise-induced asthma. The 
results showed that M&B 22,948 (Z-0-propoxyphenyl-
8azapurin-6-one) a mast cell stabilizer had no significant 
effect on histamine hypersensitivity but significant effect 
on exercise induced asthmatic complications.23 In another 
study, Holmberg et al in 1986 demonstrated the effects of 
Beclomethasone on mucociliary activity in comparison 
with placebo which revealed no significance in the 
results.24 The current study is in comparison with that 
study, especially focusing on outcome variable. The 
results showed that mucociliary transport velocity after 
one week of Bechlomethasone treatment was 7.33±1.27 
mm/minute and of mast cell stabilizer (Nedocromil 
sodium) treatment was 7.82±1.2 mm/minute with p-values 
0.558 and 0.304 showing no significant difference. 
C o n c l u s i o n  
There was no significant difference between the 
mucociliary transport velocity after treatment of 
Beclomethasone and mast cell stabilizer. This shows the 
same effectiveness of both drugs in treatment of allergic 
rhinitis. 
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